Newmark Valuation & Advisory Announces Healthcare & Seniors Housing Specialty Practice Leader, Ben Tate

September 15, 2022 9:00 AM

Newmark Valuation & Advisory (Newmark V&A) is pleased to announce the new leadership and structure of its Healthcare & Seniors Housing Specialty Practice. Benjamin A. Tate has been promoted to Senior Managing Director and Healthcare & Seniors Housing Specialty Practice Leader. Tate will work closely with Matt Yance and Tim Gillespie, MAI, both promoted to Executive Vice Presidents, and new hire, Executive Vice President Charlie Henderson, MAI. Yance, Gillespie and Henderson have been tapped to lead the Seniors Housing, Hospitals and Medical Office sub-categories, respectively.

“I am honored to lead Newmark V&A’s Healthcare & Seniors Housing Practice and am incredibly grateful to my Newmark colleagues whose collaboration has helped guide me to this point,” said Tate. “Our team’s focus will be to expand and enhance our client services, grow our team and implement key strategic actions as we continue to position Newmark V&A as the sector leader in the healthcare and seniors housing industry.”

Tate has appraised over 600 assets throughout his career, including notable portfolios for domestic and international clients. A proven leader in the industry, Tate joined Newmark in 2017 as a founding member of the Healthcare & Seniors Housing Specialty Practice.

“Newmark V&A is fortunate to have a deep talent pool of extremely knowledgeable appraisers for these specialty property types,” said V&A U.S. Practice Lead Helene Jacobson, MAI, MRICS. “With these promotions and new hires, the practice is tailored to more thoroughly cater to our clients’ needs, providing the highest level of specialization and focus for each sub-category.”

Yance, a distinguished seniors housing expert who brings nearly a decade of experience in both the private and government sectors, will lead a dedicated team specializing in valuation and advisory services for seniors housing assets. Gillespie, with over ten years of appraisal experience, specializes in the valuation of healthcare-oriented properties, with a focus on hospitals. Henderson, who focuses on medical office valuations, joins Newmark V&A with 17 years of experience from Colliers, where he most recently served as a Senior Valuation Services Director.

About Newmark
Newmark Group, Inc. (Nasdaq: NMRK), together with its subsidiaries (“Newmark”), is a world leader in commercial real estate, seamlessly powering every phase of the property life cycle. Newmark’s comprehensive suite of services and products is uniquely tailored to each client, from owners to occupiers, investors to founders, and startups to blue-chip companies. Combining the platform’s global reach with market intelligence in both established and emerging property markets, Newmark provides superior service to clients across the industry spectrum. Newmark generated revenues of nearly $3.2 billion for the twelve months ending June 30, 2022. Newmark’s company-owned offices, together with its business partners, operate from approximately 170 offices with over 6,500 professionals around the world. To learn more, visit nmrk.com or follow @newmark.

Discussion of Forward-Looking Statements about Newmark
Statements in this document regarding Newmark that are not historical facts are “forward-looking statements” that involve risks and uncertainties, which could cause actual results to differ from those contained in the forward-looking statements. These include statements about the effects of the COVID-19 pandemic on the Company’s business, results, financial position, liquidity and outlook, which may constitute forward-looking statements and are subject to the risk that the actual impact may differ, possibly materially, from what is currently expected. Except as required by law, Newmark undertakes no obligation to update any forward-looking statements. For a discussion of additional risks and uncertainties, which could cause actual results to differ from those contained in the forward-looking statements, see Newmark’s Securities and Exchange Commission filings, including, but not limited to, the risk factors and Special Note on Forward-Looking Information set forth in these filings and any updates to such risk factors and Special Note on Forward-Looking Information contained in subsequent reports on Form 10-K, Form 10-Q or Form 8-K.